Header Logo

Connection

WAYNE GOODMAN to Obsessive-Compulsive Disorder

Back to Details
This is a "connection" page, showing publications WAYNE GOODMAN has written about Obsessive-Compulsive Disorder.
WAYNE GOODMAN
Connection Strength
20.691
Obsessive-Compulsive Disorder
  1. Randomized trial comparing standard versus light intensity parent training for anxious youth. Behav Res Ther. 2024 Feb; 173:104451.
    View in: PubMed
    Score: 0.541
  2. Attenuating side effects of deep brain stimulation in the bed nucleus of the stria terminalis for obsessive compulsive disorder using current-steering strategies. Brain Stimul. 2023 Mar-Apr; 16(2):650-652.
    View in: PubMed
    Score: 0.513
  3. Obsessive Compulsive and Related Disorders. Psychiatr Clin North Am. 2023 03; 46(1):xiii-xv.
    View in: PubMed
    Score: 0.505
  4. Connectomic approaches to deep brain stimulation for OCD. Neuropsychopharmacology. 2022 03; 47(4):801-802.
    View in: PubMed
    Score: 0.469
  5. The prefrontal cortex and neurosurgical treatment for intractable OCD. Neuropsychopharmacology. 2022 01; 47(1):349-360.
    View in: PubMed
    Score: 0.461
  6. Response to: Optimizing DBS Stimulation Parameters in Obsessive-Compulsive Disorder. Neuromodulation. 2021 Feb; 24(2):400.
    View in: PubMed
    Score: 0.443
  7. Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder. Am J Psychiatry. 2021 01 01; 178(1):17-29.
    View in: PubMed
    Score: 0.440
  8. Impact of the COVID-19 pandemic on exposure and response prevention outcomes in adults and youth with obsessive-compulsive disorder. Psychiatry Res. 2021 01; 295:113597.
    View in: PubMed
    Score: 0.437
  9. Moderators and predictors of response to deep transcranial magnetic stimulation for obsessive-compulsive disorder. J Psychiatr Res. 2021 04; 136:508-514.
    View in: PubMed
    Score: 0.436
  10. Little Doubt That CBT Works for Pediatric OCD. J Am Acad Child Adolesc Psychiatry. 2020 07; 59(7):785-787.
    View in: PubMed
    Score: 0.425
  11. Deep Brain Stimulation for Intractable Obsessive-Compulsive Disorder: Progress and Opportunities. Am J Psychiatry. 2020 03 01; 177(3):200-203.
    View in: PubMed
    Score: 0.416
  12. Development and Psychometric Evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale Second Edition. J Am Acad Child Adolesc Psychiatry. 2019 01; 58(1):92-98.
    View in: PubMed
    Score: 0.378
  13. Altered olfactory processing and increased insula activity in patients with obsessive-compulsive disorder: An fMRI study. Psychiatry Res Neuroimaging. 2017 Apr 30; 262:15-24.
    View in: PubMed
    Score: 0.336
  14. Switching between internally and externally focused attention in obsessive-compulsive disorder: Abnormal visual cortex activation and connectivity. Psychiatry Res Neuroimaging. 2017 Jul 30; 265:87-97.
    View in: PubMed
    Score: 0.325
  15. Neural correlates of emotional response inhibition in obsessive-compulsive disorder: A preliminary study. Psychiatry Res. 2015 Nov 30; 234(2):259-64.
    View in: PubMed
    Score: 0.306
  16. Obsessive-compulsive disorder. Psychiatr Clin North Am. 2014 Sep; 37(3):257-67.
    View in: PubMed
    Score: 0.282
  17. Obsessive compulsive and related disorders. Psychiatr Clin North Am. 2014 Sep; 37(3):xi-xii.
    View in: PubMed
    Score: 0.282
  18. Neuromodulation for obsessive-compulsive disorder. Neurotherapeutics. 2014 Jul; 11(3):485-95.
    View in: PubMed
    Score: 0.281
  19. Psychometric properties of the Treatment-Emergent Activation and Suicidality Assessment Profile (TEASAP) in youth with OCD. Psychiatry Res. 2013 Feb 28; 205(3):253-61.
    View in: PubMed
    Score: 0.248
  20. Deep brain stimulation for intractable psychiatric disorders. Annu Rev Med. 2012; 63:511-24.
    View in: PubMed
    Score: 0.233
  21. Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Pediatr. 2012 Feb; 160(2):314-9.
    View in: PubMed
    Score: 0.230
  22. The role of avoidance in the phenomenology of obsessive-compulsive disorder. Compr Psychiatry. 2012 Feb; 53(2):187-94.
    View in: PubMed
    Score: 0.225
  23. Development and psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale--Second Edition. Psychol Assess. 2010 Jun; 22(2):223-32.
    View in: PubMed
    Score: 0.211
  24. Psychometric analysis of the Yale-Brown Obsessive-Compulsive Scale Second Edition Symptom Checklist. J Anxiety Disord. 2010 Aug; 24(6):650-6.
    View in: PubMed
    Score: 0.210
  25. Deep brain stimulation for intractable obsessive compulsive disorder: pilot study using a blinded, staggered-onset design. Biol Psychiatry. 2010 Mar 15; 67(6):535-42.
    View in: PubMed
    Score: 0.207
  26. Quality of life in children and adolescents with obsessive-compulsive disorder: base rates, parent-child agreement, and clinical correlates. Soc Psychiatry Psychiatr Epidemiol. 2009 Nov; 44(11):935-42.
    View in: PubMed
    Score: 0.194
  27. Concurrent validity of the Yale-Brown Obsessive-Compulsive Scale-Symptom Checklist. J Clin Psychol. 2008 Dec; 64(12):1338-51.
    View in: PubMed
    Score: 0.191
  28. Insight in pediatric obsessive-compulsive disorder: associations with clinical presentation. Psychiatry Res. 2008 Aug 15; 160(2):212-20.
    View in: PubMed
    Score: 0.185
  29. Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2008 May; 47(5):583-592.
    View in: PubMed
    Score: 0.183
  30. SSRI adverse events: how to monitor and manage. Int Rev Psychiatry. 2008 Apr; 20(2):203-8.
    View in: PubMed
    Score: 0.182
  31. Where does obsessive-compulsive disorder belong in DSM-V? Depress Anxiety. 2008; 25(4):336-47.
    View in: PubMed
    Score: 0.179
  32. Cognitive-behavioral therapy for obsessive-compulsive disorder: a non-randomized comparison of intensive and weekly approaches. J Anxiety Disord. 2008 Oct; 22(7):1146-58.
    View in: PubMed
    Score: 0.179
  33. Recognition and treatment of obsessive-compulsive disorder. J Clin Psychiatry. 2007 Dec; 68(12):e30.
    View in: PubMed
    Score: 0.178
  34. Sleep-related problems in pediatric obsessive-compulsive disorder. J Anxiety Disord. 2008 Jun; 22(5):877-85.
    View in: PubMed
    Score: 0.175
  35. Florida Obsessive-Compulsive Inventory: development, reliability, and validity. J Clin Psychol. 2007 Sep; 63(9):851-9.
    View in: PubMed
    Score: 0.175
  36. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Int Clin Psychopharmacol. 2007 Jul; 22(4):230-7.
    View in: PubMed
    Score: 0.173
  37. Associations between miscellaneous symptoms and symptom dimensions: an examination of pediatric obsessive-compulsive disorder. Behav Res Ther. 2007 Nov; 45(11):2593-603.
    View in: PubMed
    Score: 0.172
  38. Clinical features of children and adolescents with obsessive-compulsive disorder and hoarding symptoms. Compr Psychiatry. 2007 Jul-Aug; 48(4):313-8.
    View in: PubMed
    Score: 0.171
  39. Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches. J Am Acad Child Adolesc Psychiatry. 2007 Apr; 46(4):469-478.
    View in: PubMed
    Score: 0.170
  40. Sequential cognitive-behavioral therapy for children with obsessive-compulsive disorder with an inadequate medication response: a case series of five patients. Depress Anxiety. 2007; 24(6):375-81.
    View in: PubMed
    Score: 0.167
  41. Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder: findings from a preliminary waitlist controlled open trial. J Am Acad Child Adolesc Psychiatry. 2006 Oct; 45(10):1171-8.
    View in: PubMed
    Score: 0.164
  42. Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming. J Neurol Neurosurg Psychiatry. 2007 Mar; 78(3):310-4.
    View in: PubMed
    Score: 0.164
  43. Obsessive-compulsive disorder in Tourette syndrome. J Child Neurol. 2006 Aug; 21(8):704-14.
    View in: PubMed
    Score: 0.162
  44. Effect of comorbid tics on a clinically meaningful response to 8-week open-label trial of fluoxetine in obsessive compulsive disorder. J Psychiatr Res. 2007 Apr-Jun; 41(3-4):332-7.
    View in: PubMed
    Score: 0.162
  45. Immunology of obsessive-compulsive disorder. Psychiatr Clin North Am. 2006 Jun; 29(2):445-69.
    View in: PubMed
    Score: 0.160
  46. The children's Yale-Brown obsessive-compulsive scale: psychometric properties of child- and parent-report formats. J Anxiety Disord. 2006; 20(8):1055-70.
    View in: PubMed
    Score: 0.157
  47. The neurocircuitry of obsessive-compulsive disorder and disgust. Prog Neuropsychopharmacol Biol Psychiatry. 2006 May; 30(3):389-99.
    View in: PubMed
    Score: 0.156
  48. Clinical predictors of early fluoxetine treatment response in obsessive-compulsive disorder. Depress Anxiety. 2006; 23(7):429-33.
    View in: PubMed
    Score: 0.156
  49. Hope and coping in family members of patients with obsessive-compulsive disorder. J Anxiety Disord. 2006; 20(5):614-29.
    View in: PubMed
    Score: 0.151
  50. Factor analytic study of the Children's Yale-Brown Obsessive-Compulsive Scale. J Clin Child Adolesc Psychol. 2005 Jun; 34(2):312-9.
    View in: PubMed
    Score: 0.149
  51. Yale-Brown Obsessive Compulsive Scale: the dimensional structure revisited. Depress Anxiety. 2005; 22(1):28-35.
    View in: PubMed
    Score: 0.145
  52. Cognitive-behavioral therapy for obsessive-compulsive disorder: review of treatment techniques. J Psychosoc Nurs Ment Health Serv. 2004 Dec; 42(12):44-51.
    View in: PubMed
    Score: 0.144
  53. Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale. Psychiatry Res. 2004 Nov 30; 129(1):91-8.
    View in: PubMed
    Score: 0.144
  54. Co-occurring PTSD in intensive OCD treatment: Impact on treatment trajectory vs. response. J Affect Disord. 2024 May 15; 353:109-116.
    View in: PubMed
    Score: 0.137
  55. A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder. Biol Psychiatry. 2004 Mar 01; 55(5):553-5.
    View in: PubMed
    Score: 0.137
  56. The clinical presentation of major depressive disorder in youth with co-occurring obsessive-compulsive disorder. J Affect Disord. 2024 Mar 15; 349:349-357.
    View in: PubMed
    Score: 0.136
  57. Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive-compulsive disorder and tics. Biol Psychiatry. 2004 Jan 01; 55(1):61-8.
    View in: PubMed
    Score: 0.136
  58. A qualitative analysis of nonresponse: management of treatment-refractory obsessive-compulsive disorder. J Clin Psychiatry. 2004; 65 Suppl 14:6-10.
    View in: PubMed
    Score: 0.136
  59. Further psychometric properties of the Tourette's Disorder Scale-Parent Rated version (TODS-PR). Child Psychiatry Hum Dev. 2004; 35(2):107-20.
    View in: PubMed
    Score: 0.136
  60. Perceived worsening of obsessive-compulsive disorder symptoms after childbirth in women and men: An understudied phenomenon. Bull Menninger Clin. 2024; 88(1):48-60.
    View in: PubMed
    Score: 0.136
  61. Depressive symptoms during deep transcranial magnetic stimulation or sham treatment for obsessive-compulsive disorder. J Affect Disord. 2024 01 01; 344:466-472.
    View in: PubMed
    Score: 0.134
  62. Brain activation by disgust-inducing pictures in obsessive-compulsive disorder. Biol Psychiatry. 2003 Oct 01; 54(7):751-6.
    View in: PubMed
    Score: 0.133
  63. Dual-Target Deep Brain Stimulation for Obsessive-Compulsive Disorder and Tourette Syndrome. Biol Psychiatry. 2023 06 01; 93(11):e53-e55.
    View in: PubMed
    Score: 0.128
  64. Economic Analyses of Obsessive-Compulsive Disorder Interventions: A Systematic Review. Pharmacoeconomics. 2023 05; 41(5):499-527.
    View in: PubMed
    Score: 0.128
  65. Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder. Psychiatr Clin North Am. 2023 03; 46(1):167-180.
    View in: PubMed
    Score: 0.126
  66. Neurosurgical Approaches for Treatment-Resistant Obsessive-Compulsive Disorder. Psychiatr Clin North Am. 2023 03; 46(1):121-132.
    View in: PubMed
    Score: 0.126
  67. Cost-effectiveness analysis of radiosurgical capsulotomy versus treatment as usual for treatment-resistant obsessive-compulsive disorder. J Neurosurg. 2023 02 01; 138(2):347-357.
    View in: PubMed
    Score: 0.123
  68. Optimizing Obsessive-Compulsive Symptom Measurement With the Yale-Brown Obsessive-Compulsive Scales-Second Edition. J Psychiatr Pract. 2022 07 01; 28(4):294-309.
    View in: PubMed
    Score: 0.122
  69. Provider perceptions of telehealth and in-person exposure and response prevention for obsessive-compulsive disorder. Psychiatry Res. 2022 07; 313:114610.
    View in: PubMed
    Score: 0.121
  70. Honeycomb: a template for reproducible psychophysiological tasks for clinic, laboratory, and home use. Braz J Psychiatry. 2022 Mar-Abr; 44(2):147-155.
    View in: PubMed
    Score: 0.119
  71. Family Accommodation of Symptoms in Adults With Obsessive-Compulsive Disorder: Factor Structure and Usefulness of the Family Accommodation Scale for OCD-Patient Version. J Psychiatr Pract. 2022 01 06; 28(1):36-47.
    View in: PubMed
    Score: 0.118
  72. Genetics of childhood disorders: XXXIV. Autoimmune disorders, part 7: D8/17 reactivity as an immunological marker of susceptibility to neuropsychiatric disorders. J Am Acad Child Adolesc Psychiatry. 2002 Jan; 41(1):98-100.
    View in: PubMed
    Score: 0.118
  73. Cost-effectiveness analysis of deep transcranial magnetic stimulation relative to evidence-based strategies for treatment-refractory obsessive-compulsive disorder. J Psychiatr Res. 2022 02; 146:50-54.
    View in: PubMed
    Score: 0.118
  74. Long-term ecological assessment of intracranial electrophysiology synchronized to behavioral markers in obsessive-compulsive disorder. Nat Med. 2021 12; 27(12):2154-2164.
    View in: PubMed
    Score: 0.117
  75. Obsessive-Compulsive Disorder During the COVID-19 Pandemic: a Systematic Review. Curr Psychiatry Rep. 2021 10 06; 23(11):71.
    View in: PubMed
    Score: 0.116
  76. Systematic Review and Meta-analysis: An Empirical Approach to Defining Treatment Response and Remission in Pediatric Obsessive-Compulsive Disorder. J Am Acad Child Adolesc Psychiatry. 2022 04; 61(4):495-507.
    View in: PubMed
    Score: 0.116
  77. A Novel Framework for Network-Targeted Neuropsychiatric Deep Brain Stimulation. Neurosurgery. 2021 07 15; 89(2):E116-E121.
    View in: PubMed
    Score: 0.114
  78. Defining functional brain networks underlying obsessive-compulsive disorder (OCD) using treatment-induced neuroimaging changes: a systematic review of the literature. J Neurol Neurosurg Psychiatry. 2021 07; 92(7):776-786.
    View in: PubMed
    Score: 0.113
  79. Perceptions of Deep Brain Stimulation for Adolescents with Obsessive-Compulsive Disorder. J Child Adolesc Psychopharmacol. 2021 03; 31(2):109-117.
    View in: PubMed
    Score: 0.111
  80. Family accommodation in Chinese individuals with obsessive-compulsive disorder. Psych J. 2021 Apr; 10(2):295-304.
    View in: PubMed
    Score: 0.111
  81. Age moderated-anxiety mediation for multimodal treatment outcome among children with obsessive-compulsive disorder: An evaluation with correspondence analysis. J Affect Disord. 2021 03 01; 282:766-775.
    View in: PubMed
    Score: 0.110
  82. The Impact of Comorbidity on Cognitive-Behavioral Therapy Response in Youth with Anxiety and Autism Spectrum Disorder. Child Psychiatry Hum Dev. 2020 08; 51(4):625-635.
    View in: PubMed
    Score: 0.107
  83. Deep transcranial magnetic stimulation for obsessive compulsive disorder. Expert Rev Neurother. 2020 10; 20(10):1029-1036.
    View in: PubMed
    Score: 0.107
  84. Parent-led Behavioral Intervention for a Treatment-refusing Adult With Obsessive-Compulsive Disorder With Poor Insight and Extreme Family Accommodation. J Psychiatr Pract. 2020 03; 26(2):149-152.
    View in: PubMed
    Score: 0.104
  85. Serious negative consequences associated with exposure and response prevention for obsessive-compulsive disorder: A survey of therapist attitudes and experiences. Depress Anxiety. 2020 05; 37(5):418-428.
    View in: PubMed
    Score: 0.104
  86. Improving long term patient outcomes from deep brain stimulation for treatment-refractory obsessive-compulsive disorder. Expert Rev Neurother. 2020 01; 20(1):95-107.
    View in: PubMed
    Score: 0.102
  87. Development and psychometric evaluation of the Mandarin Chinese version of the Yale-Brown Obsessive-Compulsive Scale - Second Edition. Braz J Psychiatry. 2019 Nov-Dec; 41(6):494-498.
    View in: PubMed
    Score: 0.102
  88. Cost-Effectiveness of Treatment Alternatives for Treatment-Refractory Pediatric Obsessive-Compulsive Disorder. J Anxiety Disord. 2020 01; 69:102151.
    View in: PubMed
    Score: 0.102
  89. The Centrality of Doubting and Checking in the Network Structure of Obsessive-Compulsive Symptom Dimensions in Youth. J Am Acad Child Adolesc Psychiatry. 2020 07; 59(7):880-889.
    View in: PubMed
    Score: 0.100
  90. Parents' Perceptions of Internalizing and Externalizing Features in Childhood OCD. Child Psychiatry Hum Dev. 2019 08; 50(4):692-701.
    View in: PubMed
    Score: 0.100
  91. Predictors of treatment outcome for youth receiving intensive residential treatment for obsessive-compulsive disorder (OCD). Cogn Behav Ther. 2020 07; 49(4):294-306.
    View in: PubMed
    Score: 0.099
  92. Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial. Am J Psychiatry. 2019 11 01; 176(11):931-938.
    View in: PubMed
    Score: 0.098
  93. Chinese Therapists' Beliefs About Exposure Therapy for Anxiety and Obsessive-Compulsive Disorders. J Psychiatr Pract. 2019 05; 25(3):179-185.
    View in: PubMed
    Score: 0.098
  94. Incidence and clinical correlates of anger attacks in Chinese patients with obsessive-compulsive disorder. J Zhejiang Univ Sci B. 2019 Apr.; 20(4):363-370.
    View in: PubMed
    Score: 0.097
  95. Clinicians' perspectives of interfering behaviors in the treatment of anxiety and obsessive-compulsive disorders in adults and children. Cogn Behav Ther. 2020 01; 49(1):81-96.
    View in: PubMed
    Score: 0.097
  96. Functional neural mechanisms of sensory phenomena in obsessive-compulsive disorder. J Psychiatr Res. 2019 02; 109:68-75.
    View in: PubMed
    Score: 0.095
  97. Politically-focused intrusive thoughts and associated ritualistic behaviors in a community sample. J Anxiety Disord. 2018 05; 56:35-42.
    View in: PubMed
    Score: 0.091
  98. Impact of the 2016 US presidential election on OCD symptom presentation: A case illustration. J Clin Psychol. 2018 05; 74(5):750-754.
    View in: PubMed
    Score: 0.091
  99. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data. JAMA Psychiatry. 2017 05 01; 74(5):501-510.
    View in: PubMed
    Score: 0.085
  100. Six-Nine Year Follow-Up of Deep Brain Stimulation for Obsessive-Compulsive Disorder. PLoS One. 2016; 11(12):e0167875.
    View in: PubMed
    Score: 0.083
  101. Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial. J Psychiatr Res. 2015 Dec; 71:140-7.
    View in: PubMed
    Score: 0.077
  102. Deep Brain Stimulation for Obsessive-Compulsive Disorder: A Meta-Analysis of Treatment Outcome and Predictors of Response. PLoS One. 2015; 10(7):e0133591.
    View in: PubMed
    Score: 0.075
  103. Who qualifies for deep brain stimulation for OCD? Data from a naturalistic clinical sample. J Neuropsychiatry Clin Neurosci. 2014; 26(1):81-6.
    View in: PubMed
    Score: 0.068
  104. Surgical neuroanatomy and programming in deep brain stimulation for obsessive compulsive disorder. Neuromodulation. 2014 Jun; 17(4):312-9; discussion 319.
    View in: PubMed
    Score: 0.068
  105. Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder. Behav Res Ther. 2013 Dec; 51(12):823-9.
    View in: PubMed
    Score: 0.067
  106. Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder. J Clin Psychiatry. 2013 Jun; 74(6):e527-32.
    View in: PubMed
    Score: 0.065
  107. Long-term outcome in adults with obsessive-compulsive disorder. Depress Anxiety. 2013 Aug; 30(8):716-22.
    View in: PubMed
    Score: 0.064
  108. History of psychosurgery: a psychiatrist's perspective. World Neurosurg. 2013 Sep-Oct; 80(3-4):S27.e1-16.
    View in: PubMed
    Score: 0.064
  109. A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry. 2010 Dec 01; 68(11):1073-6.
    View in: PubMed
    Score: 0.055
  110. Refining clinical judgment of treatment outcome in obsessive-compulsive disorder. Psychiatry Res. 2011 Feb 28; 185(3):394-401.
    View in: PubMed
    Score: 0.054
  111. A case of mania following deep brain stimulation for obsessive compulsive disorder. Stereotact Funct Neurosurg. 2010; 88(5):322-8.
    View in: PubMed
    Score: 0.054
  112. Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depress Anxiety. 2010 Jun; 27(6):507-27.
    View in: PubMed
    Score: 0.053
  113. Smile and laughter induction and intraoperative predictors of response to deep brain stimulation for obsessive-compulsive disorder. Neuroimage. 2011 Jan; 54 Suppl 1:S247-55.
    View in: PubMed
    Score: 0.052
  114. Lack of benefit of accumbens/capsular deep brain stimulation in a patient with both tics and obsessive-compulsive disorder. Neurocase. 2010 Aug; 16(4):321-30.
    View in: PubMed
    Score: 0.052
  115. Cognitive behavioral therapy plus motivational interviewing improves outcome for pediatric obsessive-compulsive disorder: a preliminary study. Cogn Behav Ther. 2010; 39(1):24-7.
    View in: PubMed
    Score: 0.051
  116. Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder. J Affect Disord. 2010 Feb; 121(1-2):175-9.
    View in: PubMed
    Score: 0.050
  117. Children's Florida Obsessive Compulsive Inventory: psychometric properties and feasibility of a self-report measure of obsessive-compulsive symptoms in youth. Child Psychiatry Hum Dev. 2009 Sep; 40(3):467-83.
    View in: PubMed
    Score: 0.049
  118. Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder. Depress Anxiety. 2009; 26(1):E23-5.
    View in: PubMed
    Score: 0.048
  119. Deep brain stimulation for refractory obsessive-compulsive disorder. Front Biosci (Landmark Ed). 2009 01 01; 14(5):1880-90.
    View in: PubMed
    Score: 0.048
  120. Four-factor structure of obsessive-compulsive disorder symptoms in children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2008 Jul; 47(7):763-772.
    View in: PubMed
    Score: 0.046
  121. Further psychometric analysis of the Florida Obsessive-Compulsive Inventory. J Anxiety Disord. 2009 Jan; 23(1):124-9.
    View in: PubMed
    Score: 0.046
  122. Associations between miscellaneous symptoms and symptom dimensions in adults with obsessive-compulsive disorder. Anxiety Stress Coping. 2008 Apr; 21(2):199-212.
    View in: PubMed
    Score: 0.045
  123. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist. J Anxiety Disord. 2008 Dec; 22(8):1369-76.
    View in: PubMed
    Score: 0.045
  124. Obsessive-compulsive disorder in youth with and without a chronic tic disorder. Depress Anxiety. 2008; 25(9):761-7.
    View in: PubMed
    Score: 0.045
  125. Clinical features associated with treatment-resistant pediatric obsessive-compulsive disorder. Compr Psychiatry. 2008 Jan-Feb; 49(1):35-42.
    View in: PubMed
    Score: 0.044
  126. Family accommodation in pediatric obsessive-compulsive disorder. J Clin Child Adolesc Psychol. 2007 Apr-Jun; 36(2):207-16.
    View in: PubMed
    Score: 0.042
  127. Peer victimization in children with obsessive-compulsive disorder: relations with symptoms of psychopathology. J Clin Child Adolesc Psychol. 2006 Sep; 35(3):446-55.
    View in: PubMed
    Score: 0.041
  128. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology. 2006 Nov; 31(11):2384-93.
    View in: PubMed
    Score: 0.040
  129. Cognitive-behavioral treatment for obsessive-compulsive disorder in an elderly male with concurrent medical constraints. Am J Geriatr Psychiatry. 2006 Apr; 14(4):380-1.
    View in: PubMed
    Score: 0.040
  130. Reliability and validity of the Yale Global Tic Severity Scale. Psychol Assess. 2005 Dec; 17(4):486-91.
    View in: PubMed
    Score: 0.039
  131. Reliability and validity of the Child Behavior Checklist Obsessive-Compulsive Scale. J Anxiety Disord. 2006; 20(4):473-85.
    View in: PubMed
    Score: 0.038
  132. Obsessive compulsive symptoms in schizophrenia: frequency and clinical features. Schizophr Res. 2005 Jul 15; 76(2-3):309-16.
    View in: PubMed
    Score: 0.038
  133. Assessment of pediatric obsessive-compulsive disorder: a critical review of current methodology. Child Psychiatry Hum Dev. 2005; 36(2):195-214.
    View in: PubMed
    Score: 0.036
  134. What's in a "smile?" Intra-operative observations of contralateral smiles induced by deep brain stimulation. Neurocase. 2004 Aug; 10(4):271-9.
    View in: PubMed
    Score: 0.035
  135. A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder. J Clin Psychiatry. 2003 Jun; 64(6):640-7.
    View in: PubMed
    Score: 0.033
  136. COVID-19-related intrusive thoughts and associated ritualistic behaviors. Bull Menninger Clin. 2023; 87(3):225-249.
    View in: PubMed
    Score: 0.032
  137. Safety and efficacy of electroconvulsive therapy for depression in the presence of deep brain stimulation in obsessive-compulsive disorder. J Clin Psychiatry. 2016 05; 77(5):689-90.
    View in: PubMed
    Score: 0.020
  138. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.